Dawn S. Chandler

2.1k total citations
38 papers, 1.6k citations indexed

About

Dawn S. Chandler is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Dawn S. Chandler has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Dawn S. Chandler's work include RNA modifications and cancer (18 papers), RNA Research and Splicing (17 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Dawn S. Chandler is often cited by papers focused on RNA modifications and cancer (18 papers), RNA Research and Splicing (17 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Dawn S. Chandler collaborates with scholars based in United States and France. Dawn S. Chandler's co-authors include Ravi K. Singh, Daniel F. Comiskey, Katherine J. Ladner, Denis C. Guttridge, Carlo M. Croce, Huating Wang, Stephen J. Qualman, Alfred S.L. Cheng, Jason M. Dahlman and Hao Sun and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Dawn S. Chandler

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn S. Chandler United States 21 1.2k 522 218 153 150 38 1.6k
Kathy Astrahantseff Germany 17 645 0.5× 383 0.7× 308 1.4× 120 0.8× 84 0.6× 36 1.2k
Julie Koeman United States 20 923 0.8× 462 0.9× 365 1.7× 128 0.8× 286 1.9× 26 1.5k
Satoru Miyagi Japan 29 1.9k 1.6× 390 0.7× 301 1.4× 161 1.1× 86 0.6× 55 2.3k
Gaetano Gargiulo Netherlands 17 1.6k 1.3× 362 0.7× 407 1.9× 129 0.8× 117 0.8× 27 1.9k
Chris Haqq United States 16 1.2k 1.0× 640 1.2× 379 1.7× 237 1.5× 171 1.1× 23 1.9k
Mamie Yu United States 10 1.3k 1.1× 1.1k 2.1× 193 0.9× 252 1.6× 95 0.6× 12 1.7k
Chlöe Milsom Canada 21 664 0.6× 353 0.7× 310 1.4× 158 1.0× 95 0.6× 30 1.3k
Deqin Ma United States 21 825 0.7× 217 0.4× 196 0.9× 152 1.0× 249 1.7× 46 1.4k
Christel Kockx Netherlands 20 1.3k 1.1× 190 0.4× 150 0.7× 193 1.3× 116 0.8× 28 1.7k
Christopher Sears United States 8 989 0.8× 216 0.4× 180 0.8× 145 0.9× 104 0.7× 12 1.6k

Countries citing papers authored by Dawn S. Chandler

Since Specialization
Citations

This map shows the geographic impact of Dawn S. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn S. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn S. Chandler more than expected).

Fields of papers citing papers by Dawn S. Chandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn S. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn S. Chandler. The network helps show where Dawn S. Chandler may publish in the future.

Co-authorship network of co-authors of Dawn S. Chandler

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn S. Chandler. A scholar is included among the top collaborators of Dawn S. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn S. Chandler. Dawn S. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cripe, Timothy P., Ryan D. Roberts, Dawn S. Chandler, et al.. (2024). Progress in sarcomas: Highlights from the 2023 annual meeting of the Connective Tissue Oncology Society. SHILAP Revista de lepidopterología. 32(1). 200779–200779. 1 indexed citations
2.
Kipp, Jingjing L., Ryan D. Roberts, Nicolas Wein, et al.. (2024). Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. SHILAP Revista de lepidopterología. 32(4). 200908–200908. 3 indexed citations
3.
Cripe, Timothy P., Brian Hutzen, Mark A. Currier, et al.. (2022). Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics. Science Advances. 8(28). eabm1890–eabm1890. 9 indexed citations
4.
Comiskey, Daniel F., et al.. (2019). SRSF2 Regulation of MDM2 Reveals Splicing as a Therapeutic Vulnerability of the p53 Pathway. Molecular Cancer Research. 18(2). 194–203. 15 indexed citations
5.
Comiskey, Daniel F., et al.. (2018). RNA Splicing and Disease: Animal Models to Therapies. Trends in Genetics. 35(1). 68–87. 144 indexed citations
6.
Dominguez, Catherine, David Cunningham, & Dawn S. Chandler. (2017). SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities. Human Genetics. 136(9). 1173–1191. 9 indexed citations
7.
Comiskey, Daniel F., et al.. (2015). Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Research. 43(8). 4202–4218. 33 indexed citations
8.
Jacob, Aishwarya G., Ravi K. Singh, Daniel F. Comiskey, et al.. (2014). Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways. PLoS ONE. 9(8). e104444–e104444. 21 indexed citations
9.
Chen, Nanyue, Seetharaman Balasenthil, Jacquelyn Reuther, et al.. (2013). DEAR1 Is a Chromosome 1p35 Tumor Suppressor and Master Regulator of TGF-β–Driven Epithelial–Mesenchymal Transition. Cancer Discovery. 3(10). 1172–1189. 41 indexed citations
10.
Balkhi, Mumtaz Yaseen, O. Hans Iwenofu, Nadine Bakkar, et al.. (2013). miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR. Science Signaling. 6(286). ra63–ra63. 80 indexed citations
11.
Bebee, Thomas W., et al.. (2012). Hypoxia is a modifier of SMN2 splicing and disease severity in a severe SMA mouse model. Human Molecular Genetics. 21(19). 4301–4313. 23 indexed citations
12.
Pierson, Christopher R., Andrew Snyder, Jordan T. Gladman, et al.. (2011). Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Human Molecular Genetics. 21(4). 811–825. 53 indexed citations
13.
Gladman, Jordan T., Thomas W. Bebee, Xueyong Wang, et al.. (2010). A humanized Smn gene containing the SMN2 nucleotide alteration in exon 7 mimics SMN2 splicing and the SMA disease phenotype. Human Molecular Genetics. 19(21). 4239–4252. 23 indexed citations
14.
Chandler, Dawn S., et al.. (2009). Behavior in Organization. 69 indexed citations
15.
Wang, Huating, Ramiro Garzon, Hao Sun, et al.. (2008). NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma. Cancer Cell. 14(5). 369–381. 498 indexed citations
16.
Chandler, Dawn S., et al.. (2006). Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4. Cancer Research. 66(19). 9502–9508. 80 indexed citations
17.
Chandler, Dawn S., Junlin Qi, & William Mattox. (2003). Direct Repression of Splicing by transformer-2. Molecular and Cellular Biology. 23(15). 5174–5185. 20 indexed citations
18.
Lott, Steven T., Dawn S. Chandler, Steven A. Curley, et al.. (2002). High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.. PubMed. 62(7). 1952–5. 30 indexed citations
19.
Chandler, Dawn S.. (2001). Functionally antagonistic sequences are required for normal autoregulation of Drosophila tra-2 pre-mRNA splicing. Nucleic Acids Research. 29(14). 3012–3019. 11 indexed citations
20.
Chandler, Dawn S., Adel K. El‐Naggar, Shawn Brisbay, Raymond W. Redline, & Timothy J. McDonnell. (1994). Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: Evidence for the contribution of bcl-2 expression to renal carcinogenesis. Human Pathology. 25(8). 789–796. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy Astrahantseff Breakdown of academic impact, for papers by Julie Koeman Breakdown of academic impact, for papers by Satoru Miyagi Breakdown of academic impact, for papers by Gaetano Gargiulo Breakdown of academic impact, for papers by Chris Haqq Breakdown of academic impact, for papers by Mamie Yu Breakdown of academic impact, for papers by Chlöe Milsom Breakdown of academic impact, for papers by Deqin Ma Breakdown of academic impact, for papers by Christel Kockx Breakdown of academic impact, for papers by Christopher Sears
Rankless by CCL
2026